BEAUTYFARM MED (02373) announced that on November 28, 2025, the company repurchased 80,000 of its own shares on the market for a total consideration of approximately HK$2.0074 million, at an average price of HK$25.09 per share.
From October 15, 2025, to the date of this announcement, the company has repurchased a total of 695,000 shares for an aggregate consideration of about HK$20.6924 million.
The board of directors believes that the current trading price does not reflect the intrinsic value of the shares or the company's actual business prospects. The board is confident that the share repurchase demonstrates management's strong confidence in the long-term value of the business and will enhance the group's capital market value and shareholder returns.
The share repurchase is in the overall interests of the company and its shareholders.
Comments